Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence.
about
Enzymatic modifications of exopolysaccharides enhance bacterial persistenceStructure Analysis of the Staphylococcus aureus UDP- N -acetyl-mannosamine Dehydrogenase Cap5O Involved in Capsular Polysaccharide BiosynthesisCrystal structure of the enzyme CapF of Staphylococcus aureus reveals a unique architecture composed of two functional domainsCrystal structure of the capsular polysaccharide synthesizing protein CapE of Staphylococcus aureusDynamic elements govern the catalytic activity of CapE, a capsular polysaccharide-synthesizing enzyme from Staphylococcus aureusPopulation structure of Staphylococcus aureus from remote African Babongo PygmiesIdentification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection.Synthetic {beta}-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogensThe zwitterionic cell wall teichoic acid of Staphylococcus aureus provokes skin abscesses in mice by a novel CD4+ T-cell-dependent mechanism.Rare occurrence of methicillin-resistant Staphylococcus aureus CC130 with a novel mecA homologue in humans in GermanyAnimal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice.Capsule-negative Staphylococcus aureus induces chronic experimental mastitis in mice.Opsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens.Staphylococcus aureus gene expression in a rat model of infective endocarditis.Staphylococcus aureus CcpA affects virulence determinant production and antibiotic resistance.Antibodies to Staphylococcus aureus serotype 8 capsular polysaccharide react with and protect against serotype 5 and 8 isolatesLong term molecular epidemiology of methicillin-susceptible Staphylococcus aureus bacteremia isolates in SwedenStructural and biological characterization of a capsular polysaccharide produced by Staphylococcus haemolyticus.CD4+ T cells and CXC chemokines modulate the pathogenesis of Staphylococcus aureus wound infectionsPrevalence of clonal complexes and virulence genes among commensal and invasive Staphylococcus aureus isolates in Sweden.Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection.Identification of the capsular polysaccharides in Staphylococcus aureus clinical isolates by PCR and agglutination tests.Memory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection.Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study.Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03B adjuvant: Results of a randomized phase I trial.Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus.sigmaB and the sigmaB-dependent arlRS and yabJ-spoVG loci affect capsule formation in Staphylococcus aureusDynamic in vivo mutations within the ica operon during persistence of Staphylococcus aureus in the airways of cystic fibrosis patients.A privileged intraphagocyte niche is responsible for disseminated infection of Staphylococcus aureus in a zebrafish modelImmunomodulation and Disease Tolerance to Staphylococcus aureusPreclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.Comparison of adhesion and virulence of two predominant hospital-acquired methicillin-resistant Staphylococcus aureus clones and clonal methicillin-susceptible S. aureus isolates.MsaB activates capsule production at the transcription level in Staphylococcus aureus.Antibodies to capsular polysaccharide and clumping factor A prevent mastitis and the emergence of unencapsulated and small-colony variants of Staphylococcus aureus in mice.RpiRc Is a Pleiotropic Effector of Virulence Determinant Synthesis and Attenuates Pathogenicity in Staphylococcus aureus.Role of SCCmec type in outcome of Staphylococcus aureus bacteremia in a single medical center.Enterococcus faecalis capsular polysaccharide serotypes C and D and their contributions to host innate immune evasionPrevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli.The role of bacterial protein tyrosine phosphatases in the regulation of the biosynthesis of secreted polysaccharides.Molecular Epidemiology of Staphylococcus aureus Skin and Soft Tissue Infections in the Lao People's Democratic Republic.
P2860
Q27009503-86B6C1B7-DF53-403D-9D7B-ADC7467A3E72Q27667366-75DFDA0E-A97F-4864-AEBE-25C9C2F3B25CQ27677173-AD0B2805-691C-4C0D-9306-D0C9C1DC9BDAQ27677521-361E4B66-8622-4D0D-AE4B-A00F7EFB5BEDQ27687348-46D12CB8-B559-4DF5-9BA7-4BE9E181A6E4Q30402690-5438717D-1AB6-47BE-80BC-DC76EA8374FCQ33244198-92B1631C-A293-49F5-A248-6032177FCE79Q33613913-9FF1861D-3CF4-482E-91E8-C5EF2D5D2711Q33719517-05EEC766-BD79-4B85-90F0-3DDE392A9EBBQ34023420-09CC57E4-5582-46AA-BA3B-432A48096868Q34090161-B251FB13-2391-4BB4-9A1C-DDC46A0D2C7DQ34194538-AC94C19F-AF3D-4E16-8C41-60B01602205BQ34450382-2E37A976-C50C-4684-BA97-8236C03B8209Q34491802-012992C5-46BF-4D22-8D86-0FD2CF4C4138Q34510564-2528192A-DA6A-492F-B183-3D650A526782Q34595644-A77CE67E-6BAB-443E-8056-D1273B7FCFE6Q34639570-8A161DC4-51E4-4133-BEB4-09D8AC75F9A8Q34731479-9B63C748-BE24-4F23-B1CB-B150F237F80DQ34772232-D1C4148C-766B-4DC6-B21B-24A587F5FB01Q35018882-D6EF1338-B75E-474F-9BD8-F88FACD1979FQ35432724-B2ADB7AC-9750-4F7F-8E8C-AB140255BB89Q35690743-A490B911-7623-410A-A6D1-46BCA8E40730Q35833250-9245C837-A965-405C-8DA5-635263B461D5Q35887127-4E522E99-47AA-4C7F-A3D5-33FA61079C4DQ35887417-48D53422-1AE3-4878-9B98-5136765B2E30Q35893898-9F59060A-207B-49A7-8577-0D0320FD1524Q35947273-AB603372-F9BC-4688-870F-5FB76E56E9EFQ36208337-8B8D0914-18A7-4AA4-8117-26671F7AA6E0Q36315315-4AED43EF-490A-47D2-901D-5567D331C2D0Q36409380-F229CECF-484D-4022-B175-3E6854AE550BQ36548288-F849A0DB-676D-4AAB-9C89-67DB7BDB12F9Q36950067-8E4CB8B9-E618-4A25-8F62-4A7C2E45AA5FQ36966028-C5DA19A6-2E7B-4B27-9107-1F458F37108AQ36974423-128F069B-0EF4-4D58-80DD-5D3885017DDFQ37073997-A7DF71F8-E9B9-47CA-91FA-4366C7FADE37Q37116605-89FEF7DB-9175-4620-9E11-E617D2D4AFAFQ37451153-32666A33-641F-4510-8170-1CE5D660B1C4Q37719754-142E6CC5-ED43-4B26-B1EE-BF3F065E318FQ38167882-1D8F8B10-2427-4228-B09C-F382B39E4895Q38672473-7F2ED2E4-0764-4B52-98B2-FB81A499895D
P2860
Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Staphylococcus aureus strains ...... ccharides differ in virulence.
@ast
Staphylococcus aureus strains ...... ccharides differ in virulence.
@en
type
label
Staphylococcus aureus strains ...... ccharides differ in virulence.
@ast
Staphylococcus aureus strains ...... ccharides differ in virulence.
@en
prefLabel
Staphylococcus aureus strains ...... ccharides differ in virulence.
@ast
Staphylococcus aureus strains ...... ccharides differ in virulence.
@en
P2093
P2860
P1476
Staphylococcus aureus strains ...... ccharides differ in virulence.
@en
P2093
Andrew Watts
Anil Pillay
Anne Nicholson-Weller
Danbing Ke
Jean C Lee
P2860
P304
P356
10.1128/IAI.73.6.3502-3511.2005
P407
P577
2005-06-01T00:00:00Z